VALE DR NICHOLAS MURPHY MBBS, FRACP, FRCPA
HSANZ Council Member 2019–2023

It is with deep sadness that we announce the passing of our esteemed friend and colleague, Dr Nicholas Murphy, who died on 30 July 2025 following recurrent brain cancer.

Nick was a Clinical and Laboratory Haematologist at the Royal Hobart Hospital and a valued member of the Haematology Society of Australia and New Zealand (HSANZ). He served as the Tasmanian Councillor from 2019 to 2023 and as Membership Officer from 2021 to 2023, roles he fulfilled with distinction, generosity, and care.

Respected widely for his clinical acumen, Nick was also beloved for his dry wit, warm presence, and an enviable repertoire of dad jokes. A spirited conversationalist, he brought energy and insight to every discussion. Among Council colleagues, he was affectionately known as the resident sommelier—carefully selecting fine wines for HSANZ events and celebrations.

Nick was more than a talented haematologist—he was a mentor, role model, and friend. Many current haematologists and trainees recall his encouragement and guidance as pivotal in shaping their careers. Patients and peers alike held him in the highest regard for his thoughtful counsel, deep compassion, and unwavering commitment to care.

Nick graduated in 2002 from The University of Melbourne, completing his medical training at the Austin and Repatriation Medical Centre. He undertook an elective term in Swaziland and paused his studies briefly to travel—reflecting his lifelong curiosity and love for the world. He earned dual fellowships in FRACP and FRCPA in 2011. His career included roles at Northern Health, Western Health, and Dorevitch Pathology, and he lectured at the University of Melbourne before relocating to Hobart in 2013.

In Tasmania, Nick continued his broad work in haematology, combining public hospital care at the Royal Hobart Hospital with private practice. He contributed nationally through his involvement with the EviQ Haematology Reference Committee, the Australasian Leukaemia & Lymphoma Group (ALLG), and the Myeloma MSAG. He remained a passionate advocate for his patients and a dedicated educator of students and trainees alike.

Diagnosed in 2015, Nick faced his illness with quiet courage. Despite its profound impact, he returned to work and continued contributing meaningfully until 2023. His dedication, grace, and enduring love for life, people, and family remained undiminished throughout.

Nick is survived by his wife, Myf, and their daughters, Genevieve and Maggie. His legacy lives on—in his family, the patients he cared for, the colleagues he inspired, and the many junior doctors he mentored into the field of haematology.

We will miss him deeply. May he rest in peace.

A/Prof Hui-Peng Lee

President

Dr Pru Smith

Tasmanian Councillor